Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Valsartan/hydrochlorothiazide"'
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 3, Pp 687-691 (2021)
Abstract We tested our hypothesis that, in hypertensive patients with higher nocturnal home systolic blood pressure (HSBP) at baseline, a valsartan/cilnidipine (80/10 mg) combination would reduce nocturnal HSBP more markedly than a valsartan/hydrochl
Externí odkaz:
https://doaj.org/article/21baca87532d4d59966ef64c8ec1aadc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gavrail Poterov, Georgi Tchernev
Publikováno v:
Journal of Clinical Research in Dermatology. 7:1-4
Recently published experimental data on the presence of different types of angiotensin receptors in melanoma tissue and in breast cancer, for example, are undoubtedly alarming and indicative because Sartan therapy (in certain groups of patients) may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4756d4c4dc9fd9270cba61debe214e92
https://doi.org/10.15226/2378-1726/7/4/001125
https://doi.org/10.15226/2378-1726/7/4/001125
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. Background. The treatment-induced regression of left ventricular hypertrophy (LVH) is associated with improved prognosis in patients with arterial hypertension. However, the assessment of LVH by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47e3a60a7cd372c9a30755cd7c1f399d
https://doi.org/10.1093/ehjci/jeaa356.113
https://doi.org/10.1093/ehjci/jeaa356.113
Publikováno v:
Drug Research. 68:54-59
Aim The aim of this study is to investigate the robustness of using non-invasive saliva instead of plasma for bioequivalence of valsartan and hydrochlorothiazide (HCT) in humans based on Salivary Excretion Classification System (SECS). Methods Plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0110ca2ceabddece8ffce2e2720d5e66
https://doi.org/10.1055/s-0043-117775
https://doi.org/10.1055/s-0043-117775
Publikováno v:
Greener Journal of Medical Sciences. 7:012-017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cda8e0c63cef0132462306d6e26cfa6
https://doi.org/10.15580/gjms.2017.1.111212249
https://doi.org/10.15580/gjms.2017.1.111212249
Publikováno v:
J Clin Hypertens (Greenwich)
The effects of race and age on 24‐hour mean ambulatory systolic blood pressure (maSBP) responses to sequential 4‐week periods of angiotensin receptor blocker therapy (valsartan [VAL] 160 mg/d then 320 mg/d and combination VAL/hydrochlorothiazide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893239df7a721ca87c4417d4f31627a1
https://doi.org/10.1111/jch.12891
https://doi.org/10.1111/jch.12891
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
East and Central African Journal of Pharmaceutical Sciences; Vol 17, No 1 (2014); 25-34
A simple, rapid, sensitive, specific, accurate, precise and fast high performance liquid chromatographic method for the determination of antihypertensive drugs amlodipine, valsartan and hydrochlorothiazide singly or in combination was developed and v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::7513092bc7eea13dffcad1529bf65b7d
https://www.ajol.info/index.php/ecajps/article/view/177850
https://www.ajol.info/index.php/ecajps/article/view/177850
Autor:
Sang Wook Lim, Kyoo Rok Han, Min Su Hyon, Sang Ho Jo, Nae Hee Lee, Kwang Soo Cha, Taehoon Ahn, Sang Wook Kim, Doo Il Kim, Kiyuk Chang, Yongcheol Kim, Weon Kim, Jun Kwan, Chi Young Shim, Youngkeun Ahn, Moo Yong Rhee, Sung Yun Lee
Publikováno v:
Medicine
Background: To determine whether the effectiveness and safety of fixed-dose combinations (FDCs) of amlodipine orotate/valsartan (AML/VAL) 5/160 mg are noninferior to those of valsartan/hydrochlorothiazide (VAL/HCTZ) 160/12.5 mg in hypertensive patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91e9f3f9bac192a144bcab04e7c598e4
https://pubmed.ncbi.nlm.nih.gov/30212981
https://pubmed.ncbi.nlm.nih.gov/30212981